{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T02:51:28Z","timestamp":1792205488340,"version":"4.4.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,12,21]],"date-time":"2017-12-21T00:00:00Z","timestamp":1513814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,12,21]],"date-time":"2017-12-21T00:00:00Z","timestamp":1513814400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Oxidized low-density lipoprotein (ox-LDL)-induced vascular endothelial damage is a key event in early atherosclerosis. Safflower has been used to treat atherosclerotic heart disease in China for many years, but its molecular basis remains unclear. Hydroxysafflor yellow A (HSYA) is the main active ingredient of aqueous safflower extract. We identified the proteins involved in HSYA activity against ox-LDL-induced endothelial injury using isobaric tags for relative and absolute quantification-coupled two-dimensional liquid chromatography\u2013tandem mass spectrometry. HSYA (1, 5, or 25\u2009\u03bcM) alleviated ox-LDL-induced endothelial damage in a dose-dependent manner. We quantitated approximately 2700 protein species, of which 77 were differentially expressed following HSYA treatment. Most protein changes were related to structural molecules, metabolic enzymes, and proteins involved in signal transduction. Several differentially expressed proteins were further validated by western blot analysis. We also analysed the role of the mitochondrial membranous voltage-dependent anion-selective channel protein 2 (VDAC2) in HSYA treatment using small interfering RNA. VDAC2 functioned as a downstream anti-apoptosis effector during HSYA treatment of ox-LDL-induced endothelial impairment. These results further our understanding of the mechanisms responsible for the effects of HSYA.<\/jats:p>","DOI":"10.1038\/s41598-017-18069-4","type":"journal-article","created":{"date-parts":[[2017,12,15]],"date-time":"2017-12-15T11:44:15Z","timestamp":1513338255000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Proteomic investigation of effects of hydroxysafflor yellow A in oxidized low-density lipoprotein-induced endothelial injury"],"prefix":"10.1038","volume":"7","author":[{"given":"Feng","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhe","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingru","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,21]]},"reference":[{"key":"18069_CR1","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/362801a0","volume":"362","author":"R Ross","year":"1993","unstructured":"Ross, R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. \n                           362, 801\u2013809 (1993).","journal-title":"Nature."},{"key":"18069_CR2","doi-asserted-by":"publisher","first-page":"27219","DOI":"10.1074\/jbc.M400446200","volume":"279","author":"R Fernandes","year":"2004","unstructured":"Fernandes, R., Girao, H. & Pereira, P. High glucose down-regulates intercellular communication in retinal endothelial cells by enhancing degradation of connexin 43 by a proteasome-dependent mechanism. J Biol Chem. \n                           279, 27219\u201327224 (2004).","journal-title":"J Biol Chem."},{"key":"18069_CR3","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/S0092-8674(01)00238-0","volume":"104","author":"CK Glass","year":"2001","unstructured":"Glass, C. K. & Witztum, J. L. Atheroselerosis. the road ahead. Cell. \n                           104, 503\u2013516 (2001).","journal-title":"Cell."},{"key":"18069_CR4","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1194\/jlr.R071233","volume":"57","author":"BG Nordestgaard","year":"2016","unstructured":"Nordestgaard, B. G. & Langsted, A. Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology. J Lipid Res. \n                           57, 1953\u20131975 (2016).","journal-title":"J Lipid Res."},{"key":"18069_CR5","doi-asserted-by":"publisher","first-page":"1273042","DOI":"10.1155\/2017\/1273042","volume":"2017","author":"EA Ivanova","year":"2017","unstructured":"Ivanova, E. A., Myasoedova, V. A., Melnichenko, A. A., Grechko, A. V. & Orekhov, A. N. Small dense low-density lipoprotein as biomarker for atherosclerotic diseases. Oxid Med Cell Longev. \n                           2017, 1273042, https:\/\/doi.org\/10.1155\/2017\/1273042 (2017).","journal-title":"Oxid Med Cell Longev."},{"key":"18069_CR6","first-page":"1633","volume":"25","author":"S Deng","year":"2004","unstructured":"Deng, S. et al. Aspirin protected against endothelial damage induced by LDL: role of endogenous NO synthase inhibitors in rats. Acta Pharmacol Sin. \n                           25, 1633\u20131639 (2004).","journal-title":"Acta Pharmacol Sin."},{"key":"18069_CR7","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.cardiores.2005.09.009","volume":"68","author":"D Li","year":"2005","unstructured":"Li, D. & Mehta, J. L. Oxidized LDL, a critical factor in atherogenesis. Cardiovasc Res. \n                           68, 353\u2013354 (2005).","journal-title":"Cardiovasc Res."},{"key":"18069_CR8","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1097\/01.ASN.0000132474.50966.DA","volume":"15","author":"DH Endemann","year":"2004","unstructured":"Endemann, D. H. & Schiffrin, E. L. Endothelial dysfunction. J Am Soc Nephrol. \n                           15, 1983\u20131992 (2004).","journal-title":"J Am Soc Nephrol."},{"key":"18069_CR9","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/0891-5849(95)02173-6","volume":"20","author":"JA Berliner","year":"1996","unstructured":"Berliner, J. A. & Heinecke, J. W. The role of oxidized lipoproteins in atherosclerosis. Free Radic Biol Med. \n                           20, 707\u2013727 (1996).","journal-title":"Free Radic Biol Med."},{"key":"18069_CR10","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s10557-006-9065-1","volume":"20","author":"JL Jiang","year":"2006","unstructured":"Jiang, J. L. et al. Probucol decreases asymmetrical dimethylarginine level by alternation of protein arginine methyltransferase I and dimethylarginine dimethylaminohydrolase activity. Cardiovasc Drugs Ther. \n                           20, 281\u2013294 (2006).","journal-title":"Cardiovasc Drugs Ther."},{"key":"18069_CR11","first-page":"66","volume":"31","author":"QY Xie","year":"2006","unstructured":"Xie, Q. Y., Sun, Z. L., Chen, M. F. & Yang, T. L. Protective effect of losartan on injury induced by ox-LDL in endothelial cells and the relationship with asymmetric dimethylarginine. Zhong Nan Da Xue Xue Bao Yi Xue Ban. \n                           31, 66\u201369 (2006).","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban."},{"key":"18069_CR12","doi-asserted-by":"publisher","first-page":"207","DOI":"10.2174\/1568014043355348","volume":"3","author":"C Dessy","year":"2004","unstructured":"Dessy, C. & Ferron, O. Pathophysiological roles of nitric oxide: In the heart and the coronary vasculature. Current Medical Chemistry\u2013Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry. \n                           3, 207\u2013216 (2004).","journal-title":"Current Medical Chemistry\u2013Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry."},{"key":"18069_CR13","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1161\/CIRCRESAHA.116.309326","volume":"120","author":"U F\u00f6rstermann","year":"2017","unstructured":"F\u00f6rstermann, U., Xia, N. & Li, H. Roles of vascular oxidative stress and nitric oxide in the pathogenesis of atherosclerosis. Circ Res. \n                           120, 713\u2013735 (2017).","journal-title":"Circ Res."},{"key":"18069_CR14","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1111\/jphp.12596","volume":"68","author":"R Pan","year":"2016","unstructured":"Pan, R., Zhang, Y., Zang, B., Tan, L. & Jin, M. Hydroxysafflor yellow A inhibits TGF-\u03b21-induced activation of human fetal lung fibroblasts in vitro. J Pharm Pharmacol. \n                           68, 1320\u20131330 (2016).","journal-title":"J Pharm Pharmacol."},{"key":"18069_CR15","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s12975-014-0346-x","volume":"5","author":"Z Qi","year":"2014","unstructured":"Qi, Z. et al. AKT-related autophagy contributes to the neuroprotective efficacy of hydroxysafflor yellow A against ischemic stroke in rats. Transl Stroke Res. \n                           5, 501\u2013509 (2014).","journal-title":"Transl Stroke Res."},{"key":"18069_CR16","first-page":"1650","volume":"36","author":"XF Wang","year":"2011","unstructured":"Wang, X. F., Zang, B. X., Wu, W., Tong, J. & Jin, M. Protective effect of hydroxysafflor yellow A on endothelial cell injury induced by lipopolysaccharide. China Journal of Chinese Materia Medica. \n                           36, 1650\u20131653 (2011).","journal-title":"China Journal of Chinese Materia Medica."},{"key":"18069_CR17","first-page":"429","volume":"30","author":"M Jin","year":"2011","unstructured":"Jin, M., Pei, C. Q., Zang, B. X. & Wang, L. Inhibitory effect of hydroxysafflor yellow A on endothelium inflammatory factors expression elevation induced by platelet activating factor. Journal of Cardiovascular & Pulmonary Diseases. \n                           30, 429\u2013432 (2011).","journal-title":"Journal of Cardiovascular & Pulmonary Diseases."},{"key":"18069_CR18","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s11655-015-1976-x","volume":"22","author":"M Jin","year":"2016","unstructured":"Jin, M., Sun, C. Y. & Zang, B. X. Hydroxysafflor yellow A attenuate lipopolysaccharide-induced endothelium inflammatory injury. Chin J Integr Med. \n                           22, 36\u201341 (2016).","journal-title":"Chin J Integr Med."},{"key":"18069_CR19","doi-asserted-by":"publisher","first-page":"3002","DOI":"10.1002\/jcb.23223","volume":"112","author":"F Ye","year":"2011","unstructured":"Ye, F. et al. Comparative proteome analysis of 3T3-L1 adipocyte differentiation using iTRAQ-coupled 2D LC-MS\/MS. J Cell Biochem. \n                           112, 3002\u20133014 (2011).","journal-title":"J Cell Biochem."},{"key":"18069_CR20","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1161\/ATVBAHA.115.306964","volume":"36","author":"X Li","year":"2016","unstructured":"Li, X. et al. Mitochondrial reactive oxygen species mediate lysophosphatidylcholine-induced endothelial cell activation. Arterioscler Thromb Vasc Biol. \n                           36, 1090\u20131100 (2016).","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"18069_CR21","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S0022-2275(20)37709-9","volume":"34","author":"CP Sparrow","year":"1993","unstructured":"Sparrow, C. P. & Olszewski, J. Cellular oxidation of low density lipoprotein is caused by thiol production in media containing transition metal ions. J Lipid Res. \n                           34, 1219\u20131228 (1993).","journal-title":"J Lipid Res."},{"key":"18069_CR22","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1161\/01.ATV.0000066685.13434.FA","volume":"23","author":"D Li","year":"2003","unstructured":"Li, D., Liu, L., Chen, H., Sawamura, T. & Mehta, J. L. LOX-1,an oxidized LDL endothelial receptor,induces CD40\/CD40L signaling in human coronary artery endothelial cells. Arterioscler Thromb Vasc Biol. \n                           23, 816\u2013821 (2003).","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"18069_CR23","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1161\/01.CIR.0000047276.52039.FB","volume":"107","author":"D Li","year":"2003","unstructured":"Li, D. et al. LOX-1 mediates oxidized LDL-induced the expression and activation of matrix metalloproteinases(MMPs) in human coronary artery endothelial cells. Circulation. \n                           107, 612\u2013617 (2003).","journal-title":"Circulation."},{"key":"18069_CR24","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1161\/01.CIR.101.25.2889","volume":"101","author":"D Li","year":"2000","unstructured":"Li, D. & Mehta, J. L. Antisense to endothelial ox-LDL receptor LOX-1 inhibits ox-LDL-mediated upregulation of MCP-1 expression and monocyte adhesion to human coronary artery endothelial cells. Circulation. \n                           101, 2889\u20132896 (2000).","journal-title":"Circulation."},{"key":"18069_CR25","doi-asserted-by":"publisher","first-page":"600","DOI":"10.3389\/fphys.2017.00600","volume":"8","author":"X Yang","year":"2017","unstructured":"Yang, X. et al. Oxidative stress-mediated atherosclerosis: mechanisms and therapies. Front Physiol. \n                           8, 600, https:\/\/doi.org\/10.3389\/fphys.2017.00600 (2017).","journal-title":"Front Physiol."},{"key":"18069_CR26","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S1388-1981(02)00343-8","volume":"1585","author":"R Salvayre","year":"2002","unstructured":"Salvayre, R., Auge, N., Benoist, H. & Negre-Salvayre, A. Oxidized low-density lipoprotein-induced apoptosis. Biochim Biophys Acta. \n                           1585, 213\u2013221 (2002).","journal-title":"Biochim Biophys Acta."},{"key":"18069_CR27","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0967-2109(00)00125-3","volume":"9","author":"AY Wang","year":"2001","unstructured":"Wang, A. Y. et al. Expression of apoptosis-related proteins and structural features of cell death in explanted aortocoronary saphenous vein bypass grafts. Cardiovasc Surg. \n                           9, 319\u2013328 (2001).","journal-title":"Cardiovasc Surg."},{"key":"18069_CR28","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0021-9150(00)00489-5","volume":"154","author":"S Hata","year":"2001","unstructured":"Hata, S. et al. Vascular smooth muscle maintains the levels of Bcl-2 in endothelial cells. Atherosclerosis. \n                           154, 309\u2013316 (2001).","journal-title":"Atherosclerosis."},{"key":"18069_CR29","doi-asserted-by":"crossref","first-page":"156","DOI":"10.2310\/7750.2013.13125","volume":"18","author":"W Tausend","year":"2014","unstructured":"Tausend, W., Downing, C. & Tyring, S. Systematic review of interleukin-12, interleukin-17, and interleukin-23 pathway inhibitors for the treatment of moderate-to-severe chronic plaque psoriasis:ustekinumab, briakinumab, tildrakizumab, guselkumab, secukinumab, ixekizumab, and brodalumab. J Cutan Med Surg. \n                           18, 156\u2013169 (2014).","journal-title":"J Cutan Med Surg."},{"key":"18069_CR30","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.atherosclerosis.2015.03.036","volume":"240","author":"J Wang","year":"2015","unstructured":"Wang, J. et al. Retinol binding protein 4 induces mitochondrial dysfunction and vascular oxidative damage. Atherosclerosis. \n                           240, 335\u2013344 (2015).","journal-title":"Atherosclerosis."},{"key":"18069_CR31","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1385\/CBB:40:2:097","volume":"40","author":"N Zurgil","year":"2004","unstructured":"Zurgil, N. et al. Monitoring the apoptotic process induced by oxidized low-density lipoprotein in Jurkat T-lymphoblast and U937 monocytic human cell lines. Cell Biochem Biophys. \n                           40, 97\u2013113 (2004).","journal-title":"Cell Biochem Biophys."},{"key":"18069_CR32","doi-asserted-by":"publisher","first-page":"C82","DOI":"10.1152\/ajpcell.00287.2006","volume":"292","author":"PK Mehta","year":"2007","unstructured":"Mehta, P. K. & Griendling, K. K. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol. \n                           292, C82\u201397 (2007).","journal-title":"Am J Physiol Cell Physiol."},{"key":"18069_CR33","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1042\/CS20080155","volume":"116","author":"HP Souza","year":"2009","unstructured":"Souza, H. P. et al. Angiotensin II modulates CD40 expression in vascular smooth muscle cells. Clin Sci. \n                           116, 423\u2013431 (2009).","journal-title":"Clin Sci."},{"key":"18069_CR34","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/nature08938","volume":"464","author":"P Duewell","year":"2010","unstructured":"Duewell, P. et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature. \n                           464, 1357\u20131361 (2010).","journal-title":"Nature."},{"key":"18069_CR35","doi-asserted-by":"publisher","first-page":"8172706","DOI":"10.1155\/2016\/8172706","volume":"2016","author":"X Xu","year":"2016","unstructured":"Xu, X. et al. Hydroxysafflor yellow A inhibits LPS-induced NLRP3 inflammasome activation via binding to xanthine oxidase in mouse RAW264.7 macrophages. Mediators Inflamm. \n                           2016, 8172706, https:\/\/doi.org\/10.1155\/2016\/8172706 (2016).","journal-title":"Mediators Inflamm."},{"key":"18069_CR36","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1007\/s10495-009-0353-7","volume":"14","author":"YO Son","year":"2009","unstructured":"Son, Y. O. et al. Apoptosis-inducing factor plays a critical role in caspase-independent, pyknotic cell death in hydrogen peroxide-exposed cells. Apoptosis. \n                           14, 796\u2013808 (2009).","journal-title":"Apoptosis."},{"key":"18069_CR37","doi-asserted-by":"publisher","first-page":"11547","DOI":"10.1158\/0008-5472.CAN-07-1930","volume":"67","author":"YH Liao","year":"2007","unstructured":"Liao, Y. H., Hsu, S. M. & Huang, P. H. ARMS depletion facilitates UV irradiation induced apoptotic cell death in melanoma. Cancer Res. \n                           67, 11547\u201311556 (2007).","journal-title":"Cancer Res."},{"key":"18069_CR38","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.jmb.2007.04.073","volume":"370","author":"BW Hoogenboom","year":"2007","unstructured":"Hoogenboom, B. W., Suda, K., Engel, A. & Fotiadis, D. The supramolecular assemblies of voltage-dependent anion channels in the native membrane. J Mol Biol. \n                           370, 246\u2013255 (2007).","journal-title":"J Mol Biol."},{"key":"18069_CR39","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1126\/science.1083995","volume":"301","author":"EH Cheng","year":"2003","unstructured":"Cheng, E. H., Sheiko, T. V., Fisher, J. K., Craigen, W. J. & Korsmeyer, S. J. VDAC2 inhibits BAK activation and mitochondrial apoptosis. Science. \n                           301, 513\u2013517 (2003).","journal-title":"Science."},{"key":"18069_CR40","doi-asserted-by":"publisher","first-page":"486","DOI":"10.2174\/092986609788167824","volume":"16","author":"H Du","year":"2009","unstructured":"Du, H. et al. PSMA7, a potential biomarker of diseases. Protein Pept. Lett. \n                           16, 486\u2013489 (2009).","journal-title":"Protein Pept. Lett."},{"key":"18069_CR41","first-page":"860","volume-title":"Cancers (Basel).","author":"K Jain","year":"2014","unstructured":"Jain, K. & Basu, A. The multifunctional protein kinase c-\u03b5 in cancer development and progression. Cancers (Basel). \n                           6, 860\u2013878 (2014)."},{"key":"18069_CR42","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/nature05859","volume":"447","author":"N Yagoda","year":"2007","unstructured":"Yagoda, N. et al. RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels. Nature. \n                           447, 864\u2013868 (2007).","journal-title":"Nature."},{"key":"18069_CR43","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/35048073","volume":"2","author":"N Zamzami","year":"2001","unstructured":"Zamzami, N. & Kroemer, G. The mitochondrion in apoptosis: how Pandora\u2019s box opens. Nat Rev Mol Cell Biol. \n                           2, 67\u201371 (2001).","journal-title":"Nat Rev Mol Cell Biol."},{"key":"18069_CR44","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.bbrc.2003.07.023","volume":"313","author":"T Yoshimori","year":"2004","unstructured":"Yoshimori, T. Autophagy: A regulated bulk degradation process inside cells. Biochemical & Biophysical Research Communications. \n                           313, 453\u2013458 (2004).","journal-title":"Biochemical & Biophysical Research Communications."},{"key":"18069_CR45","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.cell.2011.10.026","volume":"147","author":"N Mizushima","year":"2011","unstructured":"Mizushima, N. & Komatsu, M. Autophagy: renovation of cells and tissues. Cell. \n                           147, 728\u2013741 (2011).","journal-title":"Cell."},{"key":"18069_CR46","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1161\/hq0701.092145","volume":"21","author":"W Li","year":"2001","unstructured":"Li, W., Dalen, H., Eaton, J. W. & Yuan, X. M. Apoptotic death of inflammatory cells in human atheroma. Arterioscler Thromb Vasc Biol. \n                           21, 1124\u20131130 (2001).","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"18069_CR47","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1248\/bpb.b15-00096","volume":"38","author":"S Kobayashi","year":"2015","unstructured":"Kobayashi, S. Choose delicately and reuse adequately: The newly revealed process of autophagy. Biological & Pharmaceutical Bulletin. \n                           38, 1098\u20131103 (2015).","journal-title":"Biological & Pharmaceutical Bulletin."},{"key":"18069_CR48","doi-asserted-by":"publisher","first-page":"H1417","DOI":"10.1152\/ajpheart.01233.2003","volume":"287","author":"X Dong","year":"2004","unstructured":"Dong, X. et al. In situ dynamically monitoring the proteolytic function of the ubiquitin-proteasome system in cultured cardiac myocytes. Am J Physiol Heart Circ Physiol. \n                           287, H1417\u20131425 (2004).","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"18069_CR49","doi-asserted-by":"publisher","first-page":"6578","DOI":"10.1021\/nn202452c","volume":"6","author":"W Liu","year":"2012","unstructured":"Liu, W. et al. Selenium nanoparticles as a carrier of 5-fluorouracil to achieve anticancer synergism. ACS Nano. \n                           6, 6578\u20136591 (2012).","journal-title":"ACS Nano."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-18069-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-18069-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-18069-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T17:13:36Z","timestamp":1671815616000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-18069-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,21]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["18069"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-18069-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,21]]},"assertion":[{"value":"2 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"17981"}}